ciclopirox has been researched along with loceryl in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (5.88) | 18.2507 |
| 2000's | 11 (32.35) | 29.6817 |
| 2010's | 19 (55.88) | 24.3611 |
| 2020's | 2 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Baran, R | 1 |
| Cohen, PR; Scher, RK | 1 |
| Baran, R; Gupta, AK; Ryder, JE | 1 |
| Reinel, D | 1 |
| Sidou, F; Soto, P | 1 |
| Baran, R; Kaoukhov, A | 1 |
| Adjadj, L; Jäckel, A; Lambert, J; Marty, JP | 1 |
| Macura, AB; Pawlik, B; Szczepko, I | 1 |
| Gensbügel, C; Jäckel, A; Neubert, RH; Wartewig, S | 1 |
| Carrillo-Muñoz, AJ; Del Valle, O; Eraso, E; Ezkurra, PA; Giusiano, G; Guardia, C; Hernández-Molina, JM; Quindós, G; Santos, P; Tur-Tur, C | 1 |
| Cantrell, W; Cathcart, S; Elewski, Be | 1 |
| Budihardja, D; Freund, V; Mayser, P | 1 |
| Burgalassi, S; Chetoni, P; Ghelardi, E; Mailland, F; Monti, D; Saccomani, L; Senesi, S | 1 |
| Berger, U; Borelli, C; Jäckel, A; Schaller, M; Schmidt, S; Walker, B; Weindl, G | 1 |
| Vera-Cabrera, L; Welsh, E; Welsh, O | 1 |
| Brown, MB; Evans, CR; Jones, SA; Khengar, RH; Traynor, MJ; Turner, RB | 1 |
| Kubota, N; Mukai, H; Nagasaka, S; Shibuya, K; Shimamura, T; Suzuki, T | 1 |
| Dal Bo, L; Herranz, U; Monti, D; Subissi, A | 1 |
| Ben Osman, A; Bienvenu, AL; Bulai-Livideanu, C; Cazeau, C; Coubetergues, H; Coustou, D; Doss, N; Fazaa, B; Lahfa, M; Mokthar, I; Nouira, R; Paul, C; Picot, S; Turki, H; Voisard, JJ; Zourabichvili, O | 1 |
| Burgalassi, S; Chetoni, P; Mailland, F; Monti, D; Tampucci, S | 1 |
| Lipner, S; Scher, RK | 1 |
| Bulgheroni, A; Celandroni, F; Ghelardi, E; Gueye, SA; Mailland, F; Salvetti, S; Senesi, S | 1 |
| Fothergill, AW; McCarthy, DI; Tavakkol, A; Wiederhold, NP | 1 |
| Borelli, C; Jäckel, A; Müller, J; Polak, A; Schaller, M; Seidl, HP | 1 |
| Borelli, C; Braunsdorf, C; Jäckel, A; Mailänder-Sanchez, D; Müller, J; Schaller, M | 1 |
| Hossin, B; Murdan, S; Rizi, K | 1 |
| Eichenfield, LF; Friedlander, SF | 1 |
| Sarkany, M; Schaller, M; Sigurgeirsson, B | 1 |
| Chakrabarti, A; Dogra, S; Mushtaq, K; Narang, T; Paul, RA; Rudramurthy, SM; Shankarnarayan, SA; Shaw, D | 1 |
| Ghannoum, M; Kunze, G; Long, L; Osman-Ponchet, H; Sarkany, M | 1 |
| Dhamoon, RK; Gupta, M; Popli, H | 1 |
| Bagger, C; Endringer Pinto, F; Janfelt, C; Joly-Tonetti, N; Kunze, G; Osman-Ponchet, H; Thénot, JP | 1 |
| Almeida, BCT; Baltazar, LM; Carmo, PHF; Dornelas, JCM; Ferreira, GF; Freitas, GJC; Peres, NTA; Santos, DA | 1 |
8 review(s) available for ciclopirox and loceryl
| Article | Year |
|---|---|
Topical and surgical treatment of onychomycosis.
Topics: Administration, Topical; Antifungal Agents; Ciclopirox; Combined Modality Therapy; Debridement; Foot Dermatoses; Hand Dermatoses; Humans; Laser Therapy; Morpholines; Onychomycosis; Pyridones | 1994 |
The use of topical therapies to treat onychomycosis.
Topics: Administration, Cutaneous; Antifungal Agents; Ciclopirox; Humans; Morpholines; Onychomycosis; Pyridones; Randomized Controlled Trials as Topic | 2003 |
Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Ciclopirox; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Morpholines; Onychomycosis; Pyridones; Risk Factors | 2005 |
Onychomycosis and diabetes.
Topics: Administration, Topical; Antifungal Agents; Ciclopirox; Diabetes Complications; Humans; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Terbinafine | 2009 |
Toenail onychomycosis in diabetic patients: issues and management.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Ciclopirox; Comorbidity; Diabetes Mellitus; Diabetic Foot; Drug Interactions; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Pyridones; Risk Factors; Terbinafine; Therapies, Investigational; Treatment Outcome | 2009 |
Onychomycosis.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Mitosporic Fungi; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Pyrimidines; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2010 |
Pediatric Onychomycosis: The Emerging Role of Topical Therapy.
Topics: Administration, Topical; Adult; Age Factors; Antifungal Agents; Child; Ciclopirox; Family; Humans; Imidazoles; Incidence; Ketoconazole; Lacquer; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Pyridones; Recurrence; Terbinafine; Tinea Pedis; Treatment Outcome | 2017 |
Novel Drug Delivery Strategies for the Treatment of Onychomycosis.
Topics: Administration, Topical; Antifungal Agents; Ciclopirox; Drug Carriers; Humans; Liposomes; Morpholines; Nail Diseases; Nanoparticles; Onychomycosis | 2019 |
4 trial(s) available for ciclopirox and loceryl
| Article | Year |
|---|---|
A randomized comparison of nail surface remanence of three nail lacquers, containing amorolfine 5%, ciclopirox 8% or tioconazole 28%, in healthy volunteers.
Topics: Adult; Antifungal Agents; Ciclopirox; Female; Humans; Imidazoles; Lacquer; Male; Morpholines; Nails; Onychomycosis; Pyridones; Soaps; Thumb | 2004 |
Nail penetration and predicted mycological efficacy of an innovative hydrosoluble ciclopirox nail lacquer vs. a standard amorolfine lacquer in healthy subjects.
Topics: Adult; Ciclopirox; Humans; Male; Middle Aged; Morpholines; Nails; Onychomycosis; Pyridones; Reference Values | 2013 |
A multicenter, randomized, open-label, controlled study comparing the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution with amorolfine nail lacquer alone in
Topics: Adolescent; Adult; Aged; Antifungal Agents; Ciclopirox; Cost-Benefit Analysis; Drug Combinations; Drug Therapy, Combination; Female; Follow-Up Studies; Foot Dermatoses; Humans; Male; Middle Aged; Morpholines; Ointments; Onychomycosis; Pyridones; Retrospective Studies; Skin Cream; Time Factors; Treatment Outcome; Young Adult | 2013 |
Patient-reported outcomes from two randomised studies comparing once-weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosis.
Topics: Administration, Topical; Adult; Aged; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Female; Foot Dermatoses; Humans; Imidazoles; Lacquer; Male; Medication Adherence; Middle Aged; Morpholines; Onychomycosis; Patient Reported Outcome Measures; Pyridones | 2017 |
22 other study(ies) available for ciclopirox and loceryl
| Article | Year |
|---|---|
[New treatments of onychomycoses].
Topics: Administration, Topical; Antifungal Agents; Candidiasis; Ciclopirox; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Morpholines; Onychomycosis; Pyridones | 1992 |
[Onychomycosis].
Topics: Antifungal Agents; Ciclopirox; Debridement; Diagnosis, Differential; Drug Therapy, Combination; Fluconazole; Griseofulvin; Humans; Imidazoles; Itraconazole; Morpholines; Mycological Typing Techniques; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Time Factors | 2004 |
Treatment costs of three nail lacquers used in onychomycosis.
Topics: Adult; Antifungal Agents; Ciclopirox; Drug Costs; Europe; Female; Foot Dermatoses; Hand Dermatoses; Humans; Imidazoles; Male; Morpholines; Onychomycosis; Pyridones | 2005 |
[The susceptibility of Aspergillus and Penicillium to recent antimycotics].
Topics: Antifungal Agents; Aspergillus; Ciclopirox; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Penicillium; Pyridones; Terbinafine | 2000 |
Different physicochemical properties of antimycotic agents are relevant for penetration into and through human nails.
Topics: Antifungal Agents; Chemical Phenomena; Chemistry, Physical; Ciclopirox; Humans; Morpholines; Nails; Permeability; Pyridones; Solubility; Spectroscopy, Fourier Transform Infrared | 2006 |
In vitro antifungal activity of sertaconazole nitrate against recent isolates of onychomycosis causative agents.
Topics: Antifungal Agents; Arthrodermataceae; Ciclopirox; Dose-Response Relationship, Drug; Fluconazole; Fungi; Humans; Imidazoles; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Thiophenes; Yeasts | 2008 |
Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity.
Topics: Absorption; Administration, Topical; Animals; Antifungal Agents; Cattle; Ciclopirox; Hoof and Claw; Humans; Lacquer; Morpholines; Nails; Onychomycosis; Permeability; Pharmaceutical Solutions; Pharmaceutical Vehicles; Pyridones; Regression Analysis; Solubility | 2010 |
Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection.
Topics: Administration, Topical; Antifungal Agents; Ciclopirox; Humans; Imidazoles; Microbial Sensitivity Tests; Models, Biological; Morpholines; Onychomycosis; Pyridones; Trichophyton | 2009 |
Effect of a novel penetration enhancer on the ungual permeation of two antifungal agents.
Topics: Adenosine Triphosphate; Administration, Topical; Antifungal Agents; Cadaver; Ciclopirox; Humans; In Vitro Techniques; Morpholines; Nail Diseases; Nails; Naphthalenes; Onychomycosis; Permeability; Pyridones; Terbinafine | 2010 |
Establishment of a novel model of onychomycosis in rabbits for evaluation of antifungal agents.
Topics: Animals; Antifungal Agents; Ciclopirox; Lacquer; Male; Models, Biological; Morpholines; Onychomycosis; Pyridones; Rabbits; Trichophyton | 2011 |
[When the nail is the polished one].
Topics: Administration, Topical; Antifungal Agents; Ciclopirox; Combined Modality Therapy; Disease Progression; Humans; Morpholines; Onychomycosis; Pyridones | 2012 |
Ciclopirox vs amorolfine: in vitro penetration into and permeation through human healthy nails of commercial nail lacquers.
Topics: Administration, Topical; Antifungal Agents; Chromatography, High Pressure Liquid; Ciclopirox; Fungi; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Morpholines; Nails; Permeability; Pyridones | 2014 |
Onychomycosis: current and future therapies.
Topics: Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Debridement; Foot Dermatoses; Hand Dermatoses; Humans; Laser Therapy; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Triazoles | 2014 |
Potential of Ergosterol synthesis inhibitors to cause resistance or cross-resistance in Trichophyton rubrum.
Topics: Antifungal Agents; Ciclopirox; Drug Resistance, Fungal; Ergosterol; Itraconazole; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Pyridones; Terbinafine; Trichophyton | 2014 |
Luliconazole demonstrates potent in vitro activity against dermatophytes recovered from patients with onychomycosis.
Topics: Antifungal Agents; Arthrodermataceae; Ciclopirox; Dermatomycoses; Humans; Imidazoles; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Terbinafine | 2014 |
Sporicidal effect of amorolfine and other antimycotics used in the therapy of fungal nail infections.
Topics: Antifungal Agents; Candida albicans; Ciclopirox; Epidermophyton; Fluconazole; Hand Dermatoses; Humans; Keratins; Microbial Sensitivity Tests; Morpholines; Nails; Naphthalenes; Onychomycosis; Pyridones; Spores, Fungal; Terbinafine; Trichophyton | 2015 |
Comparison of user-friendliness and treatment cost of Loceryl® vs. Ciclopoli®--a patient's perspective.
Topics: Administration, Topical; Adult; Antifungal Agents; Ciclopirox; Foot Dermatoses; Germany; Health Care Costs; Humans; Male; Morpholines; Nails; Onychomycosis; Patient Satisfaction; Prospective Studies; Pyridones; Surveys and Questionnaires | 2015 |
Application of Hansen Solubility Parameters to predict drug-nail interactions, which can assist the design of nail medicines.
Topics: Adolescent; Adult; Antifungal Agents; Ciclopirox; Drug Interactions; Female; Humans; Keratins; Male; Middle Aged; Morpholines; Nail Diseases; Nails; Naphthalenes; Onychomycosis; Pharmaceutical Preparations; Pyridones; Solubility; Terbinafine; Triazoles; Young Adult | 2016 |
Mutation in the Squalene Epoxidase Gene of Trichophyton interdigitale and Trichophyton rubrum Associated with Allylamine Resistance.
Topics: Allylamine; Antifungal Agents; Arthrodermataceae; Ciclopirox; Drug Resistance, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Morpholines; Squalene Monooxygenase; Terbinafine; Trichophyton; Voriconazole | 2018 |
A pilot, layerwise, ex vivo evaluation of the antifungal efficacy of amorolfine 5% nail lacquer vs other topical antifungal nail formulations in healthy toenails.
Topics: Administration, Topical; Allylamine; Antifungal Agents; Cadaver; Ciclopirox; Humans; Lacquer; Morpholines; Nails; Pilot Projects; Terbinafine; Trichophyton | 2019 |
Visualisation of penetration of topical antifungal drug substances through mycosis-infected nails by matrix-assisted laser desorption ionisation mass spectrometry imaging.
Topics: Administration, Topical; Allylamine; Antifungal Agents; Ciclopirox; Humans; Lacquer; Morpholines; Nails; Onychomycosis; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2020 |
Reactive oxygen and nitrogen species are crucial for the antifungal activity of amorolfine and ciclopirox olamine against the dermatophyte Trichophyton interdigitale.
Topics: Animals; Antifungal Agents; Arthrodermataceae; Ciclopirox; Ergosterol; Microbial Sensitivity Tests; Morpholines; Nitrogen; Onychomycosis; Oxygen; Reactive Oxygen Species; Superoxide Dismutase; Trichophyton | 2022 |